ESC Guidelines for Diabetes / Metabolic 2023

ESC Guidelines for Diabetes / Metabolic 2023

Recommendation for revascularisation in patients with diabetes

11 June 2024
Read more: Recommendation for revascularisation in patients with diabetes
ESC Guidelines for Diabetes / Metabolic 2023

Recommendations for a multifactorial approach in patients with type 2 diabetes with and without cardiovascular disease

11 June 2024
Read more: Recommendations for a multifactorial approach in patients with type 2 diabetes with and without cardiovascular disease
ESC Guidelines for Diabetes / Metabolic 2023

Recommendation for multifactorial approach to risk factors management in diabetes

11 June 2024
Read more: Recommendation for multifactorial approach to risk factors management in diabetes
ESC Guidelines for Diabetes / Metabolic 2023

Antithrombotic therapy and diabetes

11 June 2024
Read more: Antithrombotic therapy and diabetes
ESC Guidelines for Diabetes / Metabolic 2023

Recommendation for the management of dyslipidaemia in patients with diabetes

11 June 2024
Read more: Recommendation for the management of dyslipidaemia in patients with diabetes
ESC Guidelines for Diabetes / Metabolic 2023

Recommendation for blood pressure management in patients with diabetes

11 June 2024
Read more: Recommendation for blood pressure management in patients with diabetes
ESC Guidelines for Diabetes / Metabolic 2023

Hypertension and Diabetes

11 June 2024
Read more: Hypertension and Diabetes
ESC Guidelines for Diabetes / Metabolic 2023

Recommendation for glucose lowering treatment for patients with T2D and atherosclerotic CVD to reduce CVD risk

11 June 2024
Read more: Recommendation for glucose lowering treatment for patients with T2D and atherosclerotic CVD to reduce CVD risk
ESC Guidelines for Diabetes / Metabolic 2023

Glucose lowering treatment for patient with T2D and atherosclerotic cardiovascular disease to reduce cardiovascular risk

11 June 2024
Read more: Glucose lowering treatment for patient with T2D and atherosclerotic cardiovascular disease to reduce cardiovascular risk
ESC Guidelines for Diabetes / Metabolic 2023

Glucose lowering treatment for patients with T2D to reduce CVD based on the presence of atherosclerotic CVD

11 June 2024
Read more: Glucose lowering treatment for patients with T2D to reduce CVD based on the presence of atherosclerotic CVD
ESC Guidelines for Diabetes / Metabolic 2023

Recommendation for glycaemic targets in patients with Diabetes

11 June 2024
Read more: Recommendation for glycaemic targets in patients with Diabetes
ESC Guidelines for Diabetes / Metabolic 2023

Recommended guide to glycaemic targets in patients with T2D and CVD

11 June 2024
Read more: Recommended guide to glycaemic targets in patients with T2D and CVD
ESC Guidelines for Diabetes / Metabolic 2023

Recommendation for smoking cessation in patients with T2D with or without cardiovascular disease

11 June 2024
Read more: Recommendation for smoking cessation in patients with T2D with or without cardiovascular disease
ESC Guidelines for Diabetes / Metabolic 2023

Recommendation of physical exercise/activity in patients with T2D with or without CVD

11 June 2024
Read more: Recommendation of physical exercise/activity in patients with T2D with or without CVD
ESC Guidelines for Diabetes / Metabolic 2023

Recommendation for nutrition in patients with T2D diabetes with or without CVD

9 June 2024
Read more: Recommendation for nutrition in patients with T2D diabetes with or without CVD
ESC Guidelines for Diabetes / Metabolic 2023

Recommendations for reducing weight in patient with T2D with or without CVD

9 June 2024
Read more: Recommendations for reducing weight in patient with T2D with or without CVD
ESC Guidelines for Diabetes / Metabolic 2023

Recommendation for assessing Cardiovascular risk in patient with T2D

9 June 2024
Read more: Recommendation for assessing Cardiovascular risk in patient with T2D
ESC Guidelines for Diabetes / Metabolic 2023

SCORE 2- Diabetes: estimating 10 year cardiovascular risk

8 June 2024
Read more: SCORE 2- Diabetes: estimating 10 year cardiovascular risk
ESC Guidelines for Diabetes / Metabolic 2023

Cardiovascular risk categories in T2D

8 June 2024
Read more: Cardiovascular risk categories in T2D
ESC Guidelines for Diabetes / Metabolic 2023

Recommendation for diagnosing diabetes

8 June 2024
Read more: Recommendation for diagnosing diabetes

< Diabetes / Metabolic Guidelines